Literature DB >> 780281

[The importance of serum components, particularly complement factors, properdin and transferrin, in inhibition of bacterial growth by human serum (author's transl)].

M Fürbeth, D Adam.   

Abstract

In this study human serum was broken down of column chromatography into its protein components, which were than examined singly and in comnination for antibacterial activity. The bactericidal effect of serum was retained to an apperciable extent in only one of six fractions. Antibacterial inhibitory activity could be restored fully by combining the fractions however. There was no correlation with the specific antibody titers. Complement had an essential part in this unspecific defence. In the absence of C'9 all other combinations of the remanining complement components exhibited no appreciable inhibitory effect. Not all complement componets are required, however, for unspcific bacterial growth inhibition. In contrast to this all complement components are necessary in the antigen-antibody reaction. Futhermore, properdin displays bactericidal activity which is related to the presence of complements. A great deal of the antibacterial activity of human serum thus arises only from the combined action of several components. These do not include proteins with a molecular weight between 100,000 and 70,000, whereby transferrin plays a part.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 780281     DOI: 10.1007/bf01638725

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  [Studies on quantitative serum properdin determination].

Authors:  W KOEGLER; F SCHEIFFARTH; W FRENGER
Journal:  Acta Haematol       Date:  1961-01       Impact factor: 2.195

2.  Antibacterial systems of serum in relation to nonspecific immunity to infection.

Authors:  D ROWLEY
Journal:  Bacteriol Rev       Date:  1960-03

3.  Quantitative studies on the bactericidal actions of serum and complement. II. Some implications for the mechanism of the bactericidal reaction.

Authors:  L H MUSCHEL; H P TREFFERS
Journal:  J Immunol       Date:  1956-01       Impact factor: 5.422

4.  On the Bactericidal Effect exerted by Human Blood on certain species of Pathogenic Micro-Organisms and on the Antibactericidal Effects obtained by the addition to the blood in vitro of Dead Cultures of the Micro-Organisms in question.

Authors:  A E Wright; F N Windsor
Journal:  J Hyg (Lond)       Date:  1902-10-01

5.  An Iron-binding Component in Human Blood Plasma.

Authors:  A L Schade; L Caroline
Journal:  Science       Date:  1946-10-11       Impact factor: 47.728

6.  Some observations on bactericidal Complement.

Authors:  E Steinhardt
Journal:  J Med Res       Date:  1905-11

7.  Hereditary deficiency of the second component of complement (C'2) in man.

Authors:  M R Klemperer; H C Woodworth; F S Rosen; K F Austen
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

8.  [Serum resistance and "nephropathogenicity" of antigenetically defined E. coli strains. II. Behavior of different serum resistant bacilli in vitro].

Authors:  W Henkel
Journal:  Z Med Mikrobiol Immunol       Date:  1971

9.  A kinetic study of the bacteriolytic and bactericidal action of human serum.

Authors:  A A Glynn; C M Milne
Journal:  Immunology       Date:  1967-06       Impact factor: 7.397

10.  Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins.

Authors:  M R Smith; H S Shin; W B Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

View more
  2 in total

Review 1.  Protein binding: do we ever learn?

Authors:  Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

Review 2.  Antimicrobial Activity and Resistance: Influencing Factors.

Authors:  Jun Li; Shuyu Xie; Saeed Ahmed; Funan Wang; Yufeng Gu; Chaonan Zhang; Ximan Chai; Yalan Wu; Jinxia Cai; Guyue Cheng
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.